Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

NCT00225277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pioglitazone
DRUG: Glimepiride

Sponsor

Takeda